CardioScale


Medical device company (founded 2012) developing a non-invasive, algorithmic hemodynamic index and associated portable monitoring hardware for early detection of patient deterioration. Technology combines multiple vital signs into a single predictive indicator intended for point-of-care use in hospitals, EMS, military/first-response and mass-casualty triage. The company has peer-reviewed publications, regulatory milestones (CE mark) and multiple granted patents.

Industries

fitness
health-care
health-diagnostics
medical-device
wellness

Nr. of Employees

small (1-50)


Products

Portable multi-parameter field monitor (arm-cuff) with on-device hemodynamic index calculation

A compact, portable monitor designed to measure multiple vital signs (blood pressure, heart rate, respiratory rate, oximetry, capnography) and compute a non-invasive hemodynamic reserve index for point-of-care assessment.

Hemodynamic reserve index calculator (software/algorithm)

A software/algorithmic calculator that integrates multiple vital signs to produce a cardiovascular reserve index intended to indicate current hemodynamic status and predict deterioration.


Services

Technical integration and implementation of the non-invasive hemodynamic index into existing patient monitoring systems to support deterioration detection and treatment response analysis.

Expertise Areas

  • Non-invasive hemodynamic monitoring
  • Point-of-care multi-parameter vital-sign monitoring
  • Algorithmic patient deterioration prediction
  • Medical device hardware and embedded software development
  • Show More (4)

Key Technologies

  • Multi-vital-sign hemodynamic index (non-invasive)
  • Portable cuff-based vital-sign monitor
  • Blood pressure monitoring
  • Pulse oximetry
  • Show More (3)

News & Updates

Awarded first prize in the 2018 Combating Terrorism Technology Start-Up Challenge, recognized for technology applicable to triage and mass-casualty events.

Regulatory milestone: CE marking for the cardiovascular reserve index calculator.

Multiple peer-reviewed articles and conference abstracts covering the cardiovascular reserve index concept, exercise and heat intolerance studies, and a swine hemorrhage model validating the index.

Company CEO interviewed discussing the early-detection hemodynamic technology (interview in Hebrew).

Announcements of patent grants for the hemodynamic reserve index in jurisdictions including the United States, China, Japan and Australia.

Swine exsanguination model study reported that the hemodynamic index predicted hemorrhage-related deterioration with high accuracy in that preclinical study.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.